Myomo (MYO) Other Operating Expenses (2022 - 2025)

Myomo's (MYO) quarterly Other Operating Expenses came in at $1.5 million in Q3 2025, down 23.67% on a QoQ basis from $2.0 million in Q2 2025.

Myomo (MYO) Other Operating Expenses (2022 - 2025) Analysis & Trends

Myomo (MYO) has 3 years of Other Operating Expenses data on file, last reported at $1.5 million in Q3 2025.

Quarterly Other Operating Expenses changed N/A year-over-year to $1.5 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was $5.3 million (changed N/A YoY) and the FY2023 annual result came in at -$785.0, up 28.7% from the prior year.
Other Operating Expenses slipped to $1.5 million in Q3 2025, from $2.0 million in the prior quarter.
In the past five years, Other Operating Expenses ranged from a high of $2.0 million in Q2 2025 to a low of -$6883.0 in Q4 2023.
A 3-year average of $484313.3 and a median of $467.0 in 2023 frame the typical range for Other Operating Expenses.
The widest YoY moves for Other Operating Expenses: up 3512.73% in 2023, down 147.34% in 2023.
Tracing MYO's Other Operating Expenses over 3 years: stood at $14539.0 in 2022, then sank by 147.34% to -$6883.0 in 2023, then jumped by 22294.68% to $1.5 million in 2025.
The last three Other Operating Expenses figures came in at $1.5 million (Q3 2025), $2.0 million (Q2 2025), and $1.8 million (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	200.20 Bn	194.60 Bn	7.27 Bn
2	Stryker	129.69 Bn	126.21 Bn	4.50 Bn
3	Medtronic	120.14 Bn	110.92 Bn	6.41 Bn
4	Boston Scientific	74.16 Bn	73.62 Bn	3.85 Bn
5	Edwards Lifesciences	52.68 Bn	48.43 Bn	1.35 Bn
6	Dexcom	34.57 Bn	32.62 Bn	830.00 Mn
7	GE HealthCare Technologies	34.09 Bn	31.98 Bn	2.18 Bn
8	Koninklijke Philips	26.49 Bn	23.17 Bn	4.55 Bn
9	Steris	23.19 Bn	22.70 Bn	684.20 Mn
10	Myomo	72.95 Mn	53.98 Mn	-

Download Data